Proteome Systems abandons prostate cancer test development

Proteome sells exclusive license to DiagnostIQ test to Bayer CropScience

From testing fat in sausages to dissecting the proteome of the lung-infecting fungus Cryptococcus gattii - it's been quite a journey for Associate Professor Ben Herbert, one of the speakers at this week's AOHUPO/PRICPS conference in Cairns.

Proteome Systems step closer to TB diagnostic feasibility

Matt Padula is part of a team at UTS that is using de novo peptide sequencing of the proteins and enzymes in a common tick to look for candidate antigens for a potential vaccine against one of Australia's deadliest parasites.

Sputum-based test to be developed by Proteome Systems and BD.

Dr Jenny Harry has been appointed CEO of Proteome Systems and has announced a new $5m deal.

Ross Dobinson has been appointed as Acrux's (ASX:ACR) non-executive chairman, replacing Nuno D'Aquino who is stepping down due to private commitments. D'Aquino will continue as a non-executive director and will chair the board's Human Capital Committee.

Six months from completing an 18-month collaboration with the US-based High Q Foundation, Sydney's Proteome Systems (ASX:PXL) has statistically validated some of the multiple biomarkers for the inherited neurodegenerative disorder Huntington's disease which it identified in an earlier smaller study.

Biotech shares bucked the trend during the month of October - the Intersuisse biotechnology index gained 6.6 per cent in contrast to the All Ordinaries and the Nasdaq Biotech Index, which fell by 3.9 per cent and 3.8 per cent respectively.

Proteome Systems (ASX:PXL) founder Dr Keith Williams is no longer a director of the company he established in 1999, following his decision to withdraw his nomination for re-election at yesterday's AGM.